UPB Stock Price | Upstream Bio, Inc. P/E, Revenue, EPS, & Forecasts

Upstream Bio, Inc. • UPB

Capital at risk.

About
Metrics
Forecasts
Earnings performance
Financial performance
Sentiment analysis
FAQs

About Upstream Bio, Inc.

Ticker

UPB

Trading on

NASDAQ

ISIN

US91678A1079

Industry

Biotechnology

Sector

Healthcare

CEO

Dr. E. Rand Sutherland M.D., M.P.H., MPH

Headquarters

890 Winter Street, Waltham, MA, United States, 02451

Employees

Website

https://upstreambio.com

Upstream Bio, Inc., a clinical-stage biotechnology company, develops treatments for inflammatory diseases focusing on severe respiratory disorders. Its product candidate includes verekitug, which is in Phase 2 clinical development for the treatment of severe asthma and chronic rhinosinusitis with nasal polyps, as well as in Phase I clinical trial for treating chronic obstructive pulmonary disease. The company was incorporated in 2021 and is headquartered in Waltham, Massachusetts.

Metrics

BasicAdvanced

Market cap

$1.26B

P/E ratio

EPS

-$6.40

Dividend Yield

0.00%

Beta

Forward P/E ratio

EBIDTA

$-140M

Ex dividend date

Price & volume

Market cap

$1.26B

Average daily volume

0.5M

90-day return

30-day return

7-day return

Dividends

Dividend per share

$0.00

Dividend yield

0.00%

Forward dividend per share

$0.00

Forward dividend yield

0.00%

Payout ratio

0.00%

Valuation

P/E ratio

Forward P/E

PEG ratio

Trailing P/E

Price to sales

535.56

Price to book

3.57

Earnings

EPS

-$6.40

EPS estimate (current quarter)

-$0.78

EPS estimate (next quarter)

-$0.79

EBITDA

$-140M

Revenues (TTM)

$2.8M

Revenues per share (TTM)

$0.05

Technicals

Beta

52-week High

$33.00

52-week Low

$5.14

50-day moving average

$20.33

200-day moving average

$13.03

Short ratio

7.89

Short %

9.78%

Management effectiveness

ROE (TTM)

-40.80%

ROA (TTM)

-28.15%

Profit margin

0.00%

Gross profit margin

$2.8M

Operating margin

-5,539.39%

Growth

Quarterly earnings growth (YoY)

0.00%

Quarterly revenue growth (YoY)

12.50%

Share stats

Outstanding Shares

54M

Float

28.7M

Insiders %

14.77%

Institutions %

93.30%

Analyst Insights & forecasts

100% Buy

0% Hold

0% Sell

Based on information from 4 analysts.

Average price target

$49.75

Earnings per share (EPS) forecast

windowbar_chart_4_bars

Actual

Expected

Surprise

-$0.41

-$0.54

24.12%

Q4 • 24Beat

-$0.51

-$0.48

-6.25%

Q1 • 25Missed

-$0.74

-$0.61

-21.31%

Q2 • 25Missed

-$0.63

-$0.77

18.18%

Q3 • 25Current

QuarterlyAnnual

Financial Performance

windowbar_chart_4_bars

Income StatementBalance SheetCash Flow

windowbar_chart_4_bars

Revenue

Net income

Profit margin

$0.9M

$-40M

-4,265.31%

Q2 • 25

$0.7M

$-33.7M

-4,941.14%

Q3 • 25

-27.11%

-15.56%

15.84%

QoQ growth

QuarterlyAnnual

Totals assets

Total liabilities

Debt to assets

$421M

$11.8M

2.80%

Q2 • 25

$391M

$12.6M

3.22%

Q3 • 25

-6.97%

7.07%

15.10%

QoQ growth

QuarterlyAnnual

Operating

Investing

Financing

Free cash flow

$-39.2M

$12.8M

$0.6M

$-39.3M

Q2 • 25

$-22.2M

$48.2M

$0.8M

$-22.2M

Q3 • 25

-43.32%

277.25%

24.18%

-43.51%

QoQ growth

QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a Upstream Bio, Inc. share?

Upstream Bio, Inc. shares are currently traded for undefined per share.

How many shares does Upstream Bio, Inc. have?

Upstream Bio, Inc. currently has 54M shares.

Does Upstream Bio, Inc. pay dividends?

No, Upstream Bio, Inc. doesn't pay dividends.

What is Upstream Bio, Inc. 52 week high?

Upstream Bio, Inc. 52 week high is $33.00.

What is Upstream Bio, Inc. 52 week low?

Upstream Bio, Inc. 52 week low is $5.14.

What is the 200-day moving average of Upstream Bio, Inc.?

Upstream Bio, Inc. 200-day moving average is $13.03.

Who is Upstream Bio, Inc. CEO?

The CEO of Upstream Bio, Inc. is Dr. E. Rand Sutherland M.D., M.P.H., MPH.

How many employees Upstream Bio, Inc. has?

Upstream Bio, Inc. has 52 employees.

What is the market cap of Upstream Bio, Inc.?

The market cap of Upstream Bio, Inc. is $1.26B.

What is the P/E of Upstream Bio, Inc.?

The current P/E of Upstream Bio, Inc. is null.

What is the EPS of Upstream Bio, Inc.?

The EPS of Upstream Bio, Inc. is -$6.40.

What is the PEG Ratio of Upstream Bio, Inc.?

The PEG Ratio of Upstream Bio, Inc. is null.

What do analysts say about Upstream Bio, Inc.?

According to the analysts Upstream Bio, Inc. is considered a buy.